首页 | 本学科首页   官方微博 | 高级检索  
     


A germline variant N375S in MET and gastric cancer susceptibility in a Chinese population
Authors:Yao Liua  Qin Zhanga  Chuanli Renb  Yanbing Dingc  Guangfu Jina  d  Zhibin Hua  d  Yaochu Xua  Hongbing Shena  b a
Affiliation:Department of Epidemiology and Biostatistics,MOE Key Laboratory of Modern Toxicology,School of Public Health,Nanjing Medical University,Nanjing,Jiangsu 210029,China;bMedical Laboratory,Northern Jiangsu People’s Hospital,Yangzhou,Jiangsu 225001,China;cDepartment of Gastroenterology,Yangzhou First People’s Hospital,Yangzhou,Jiangsu 225009,China;dSection of Clinical Epidemiology,Jiangsu Key Laboratory of Cancer Biomarkers,Prevention and Treatment,Cancer Center,Nanjing Medical University,Nanjing,Jiangsu 210029,China.Received 27 July 2011,Revised 02 September 2011,Accepted 20 September 2011,Epub 29 March 2012
Abstract:
MET tyrosine kinase and its ligand,hepatocyte growth factor(HGF),play a pivotal role in the activties of tumor cells.A germline missense variant in exon 2 of the MET gene,N375S(rs33917957 A>G),may alter the binding affinity of MET for HGF and thus modify the risk of tumorigenesis.In this study,we performed a case-control study to assess the association between N375S and gastric cancer risk in 1,681 gastric cancer cases and 1,858 cancer-free controls.Logistic regression analysis was applied to estimate crude and adjusted odds ratios(ORs) and 95% confidence intervals(CIs) for the associations between genotypes and gastric cancer risk.We found that MET N375S variant genotypes(NS/SS) were associated with a significantly decreased risk of gastric cancer(OR = 0.78,95% CI = 0.63-0.96,P = 0.021) compared with the wildtype homozygote(NN).The finding indicates that this germline variant in MET may decrease gastric cancer susceptibility in Han Chinese.
Keywords:MET  germline variation  gastric cancer  susceptibility
本文献已被 CNKI ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号